1. Home
  2. EXPO vs TMDX Comparison

EXPO vs TMDX Comparison

Compare EXPO & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EXPO
  • TMDX
  • Stock Information
  • Founded
  • EXPO 1967
  • TMDX 1998
  • Country
  • EXPO United States
  • TMDX United States
  • Employees
  • EXPO N/A
  • TMDX N/A
  • Industry
  • EXPO Professional Services
  • TMDX Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • EXPO Consumer Discretionary
  • TMDX Health Care
  • Exchange
  • EXPO Nasdaq
  • TMDX Nasdaq
  • Market Cap
  • EXPO 4.0B
  • TMDX 4.8B
  • IPO Year
  • EXPO 1990
  • TMDX 2019
  • Fundamental
  • Price
  • EXPO $72.34
  • TMDX $115.68
  • Analyst Decision
  • EXPO Strong Buy
  • TMDX Buy
  • Analyst Count
  • EXPO 1
  • TMDX 9
  • Target Price
  • EXPO $120.00
  • TMDX $129.88
  • AVG Volume (30 Days)
  • EXPO 344.1K
  • TMDX 909.2K
  • Earning Date
  • EXPO 07-31-2025
  • TMDX 07-30-2025
  • Dividend Yield
  • EXPO 1.64%
  • TMDX N/A
  • EPS Growth
  • EXPO 3.59
  • TMDX N/A
  • EPS
  • EXPO 2.04
  • TMDX 1.41
  • Revenue
  • EXPO $518,720,000.00
  • TMDX $488,227,000.00
  • Revenue This Year
  • EXPO $4.23
  • TMDX $34.07
  • Revenue Next Year
  • EXPO $7.20
  • TMDX $20.76
  • P/E Ratio
  • EXPO $35.94
  • TMDX $82.00
  • Revenue Growth
  • EXPO 2.58
  • TMDX 64.43
  • 52 Week Low
  • EXPO $72.43
  • TMDX $55.00
  • 52 Week High
  • EXPO $115.75
  • TMDX $177.37
  • Technical
  • Relative Strength Index (RSI)
  • EXPO 39.37
  • TMDX 38.66
  • Support Level
  • EXPO $73.96
  • TMDX $109.59
  • Resistance Level
  • EXPO $77.11
  • TMDX $127.97
  • Average True Range (ATR)
  • EXPO 1.96
  • TMDX 5.57
  • MACD
  • EXPO -0.18
  • TMDX -2.35
  • Stochastic Oscillator
  • EXPO 0.71
  • TMDX 22.52

About EXPO Exponent Inc.

Exponent Inc is a science and engineering consulting firm that provides solutions to complex problems. The company's consultant team is composed of scientists, physicians, engineers, as well as business and regulatory consultants. The company currently operates through two segments. The engineering and other scientific segments, which account for the majority of revenue, provide servicing encompassing biomechanics, biomedical engineering, buildings and structures, civil engineering, construction consulting, etc. The environmental and health segment covers chemical regulation and food safety, ecological and biological sciences, environmental and earth sciences and others. The company generates almost all of its revenues from America.

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

Share on Social Networks: